Ibogaine Treatment

At Crossroads Ibogaine Treatment Center, we believe each person’s individual needs must be met to treat the addiction successfully. An imbalance in brain chemistry causes chemical dependency, and these imbalances are different for everyone. Hence, our tailored Ibogaine treatment is primarily focused on correcting the unique imbalances within each patient’s specific brain chemistry.

Our individualized Ibogaine treatment is specifically designed to heal the brain’s neurochemistry to a balanced and properly functioning state. As Ibogaine resets the dopamine uptake pathways, we are able to reverse the obsession driving the addiction. Before Ibogaine treatment, the addictive substances are altering your thoughts, emotions, and behaviors. Post-Ibogaine treatment, you are back in control and free to think, feel, and act in accordance with new goals and visions. Ibogaine treatments are monitored and guided, so you will have the opportunity to identify what went wrong and what needs to happen to get back on track with the life you desire and deserve.

To maximize the success behind your recovery and ensure a permanent transition, Crossroads offers Continuing Care. Continuing Care helps you identify where you want to go and how to get there. Your new recovery is supported through daily focuses and exercises, therapeutic sessions, education, life skills, and ongoing coaching. Continuing Care connects you with your passion, purpose, and mission in life. Continuing Care helps you restore your relationships, career, health, and life. Our Ibogaine treatment will take you there;

Continuing Care keeps you moving forward. Crossroads Ibogaine Treatment Center’s Ibogaine treatment Center is the world’s leader in curing physical dependency and withdrawal symptoms. We specialize in Alcohol, Cocaine, Heroin, Methadone, Suboxone, Meth-amphetamine, and Prescription Opiate addictions.

While Crossroads Ibogaine Treatment Center’s Ibogaine treatment is the world’s leading addiction cure, not everyone is right for this treatment. Patients who have an active disease affecting the heart, lung, or liver may not be eligible.